Personalized and Genomic Cancer Therapy
Cancer, once a monolithic adversary, now unveils its secrets to the discerning gaze of personalized medicine. Personalized and Genomic Cancer Therapy emerges as a vanguard journal, illuminating the intricate pathways of genomic variation and charting the course towards individualized, transformative treatments. Here, we celebrate the dawn of a new era in cancer care, where genetic blueprints guide therapeutic decisions, empower patients, and rewrite the narrative of this once-feared disease.
Access policy: Open access
Review policy: Double-blind peer review
Frequency: Publish continuously